MRSH
Next earnings: Jul 16, 2026 · Before open
Signal
Leaning Bearish1
Price
1
Move-0.91%Quiet session
Volume
1
Volume0.8× avgNormal activity
Technical
1
TrendFull DowntrendBelow 50D & 200D
PRICE
Prev Close
167.71
Open
168.94
Day Range166.00 – 171.03
166.00
171.03
52W Range164.89 – 235.78
164.89
235.78
2% of range
VOLUME & SIZE
Avg Volume
3.2M
Float
481.8M
FUNDAMENTALS
P/E Ratio
20.8x
EPS (TTM)
$7.99
Div Yield
No dividend
Performance
1D
-0.91%
5D
-1.70%
1M
-4.83%
3M
-11.72%
6M
-6.72%
YTD
-10.42%
1Y
-26.89%
Worst: 1Y (-26.89%)
Quick Read
Trend
DOWNTREND
Price below SMA50 & SMA200
Momentum
BULLISH
revenue +10% YoY · 42% gross margin
Valuation
FAIR
P/E 21x vs ~20x sector
Health
STRONG
CR 11.5 · FCF $10.18/sh
Bullish
Key MetricsTTM
Market Cap$80.06B
Revenue TTM$27.52B
Net Income TTM$3.92B
Free Cash Flow$4.93B
Gross Margin42.4%
Net Margin14.3%
Operating Margin21.7%
Return on Equity25.9%
Return on Assets6.7%
Debt / Equity1.54
Current Ratio11.46
EPS TTM$8.11
Alpha SignalsFull Analysis →
What Moves This Stock

Organic revenue growth rate in Risk & Insurance Services (target: 5-7% annually), driven by new business wins, client retention, and insurance rate environment

Insurance pricing trends (hard market vs soft market): rising commercial P&C rates increase premiums and thus commission revenue without additional effort

Mercer consulting bookings and project pipeline, particularly large-scale HR transformation and pension de-risking mandates

Margin expansion initiatives and operating leverage realization as revenue grows faster than expenses

Macro Sensitivity
Economic Cycle

moderate - Insurance brokerage revenue correlates with commercial activity (more business expansion = more insurable exposures), but recurring renewal revenue provides downside protection. Consulting is more cyclical as corporations defer discretionary projects during recessions. Overall, the mix creates moderate GDP sensitivity with 60-70% correlation to business investment cycles. Historically, organic growth slows to 2-3% in recessions vs 6-8% in expansions.

Interest Rates

Rising rates have mixed impact. Positive: higher fiduciary investment income on client funds held temporarily (~$10-15B average balance) adds 5-10bps to margins per 100bps rate increase. Negative: higher discount rates compress valuation multiples for high-quality service businesses. Minimal direct financing cost impact given low net debt position (1.4x Debt/Equity is manageable for cash-generative business). Overall, modest positive operational benefit from rates, but valuation headwind in rising rate environments.

Key Risks

Disintermediation risk: Direct-to-insurer digital platforms and insurer-owned distribution could bypass traditional brokers for standardized commercial risks, though complex risks still require expert intermediation

Regulatory changes: Potential commission disclosure requirements or fee structure mandates (similar to UK reforms) could pressure margins or alter business model economics

Talent retention: Business depends on relationships held by individual brokers and consultants; high-profile departures to competitors can result in client losses

Investor Profile

quality growth - Investors value the recurring revenue model, consistent mid-to-high single-digit organic growth, strong free cash flow generation (5.7% FCF yield), and capital return program (3-4% dividend yield plus buybacks). The stock attracts long-term institutional holders seeking defensive growth with lower volatility than cyclical financials. Recent 22.6% one-year decline likely reflects multiple compression from rising rates and growth concerns, creating potential value entry point for quality-focused investors.

Watch on Earnings
Commercial insurance rate change index (Council of Insurance Agents & Brokers): positive rate environment directly increases commission revenueGlobal M&A transaction volume: drives demand for transactional risk insurance and deal advisory servicesCorporate profit margins and business confidence surveys: leading indicators for insurance buying and consulting project budgetsEmployment growth and wage inflation: drives group benefits enrollment and HR consulting demand at Mercer
Health Radar
3 strong1 watch2 concern
57/100
Liquidity
11.46Strong
Leverage
1.54Watch
Coverage
6.3xStrong
ROE
25.9%Strong
ROIC
7.7%Concern
Cash
$2.7BConcern
ANALYST COVERAGE32 analysts
HOLD
+20.4%upside to target
L $190.00
Med $200.00consensus
H $236.00
Strong Buy
13%
Buy
1031%
Hold
2063%
Sell
13%
11 Buy (34%)20 Hold (63%)1 Sell (3%)
Full report →
Stock Health
Composite Score
2 of 7 signals bullish
3/10
Trend
Trend StateDowntrend (below both MAs)
Above SMA 50$175.38 (-5.2%)
Above SMA 200$187.77 (-11.5%)
Technicals
MA AlignmentDeath Cross (50D vs 200D -6.6%)
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusHold
~
LiquidityCurrent Ratio 11.46 — healthy liquidity
Upcoming Events
EEarnings Report · After CloseMay 4, 2026
Tomorrow
DEx-Dividend DateJul 31, 2026
In 89 days
PDividend PaymentAug 14, 2026
In 103 days
Technicals
Market Position
Price Levels
52W High
$235.8+41.9%
SMA 200
$187.8+13.0%
SMA 50
$175.4+5.5%
Current
$166.2
52W Low
$164.9-0.8%
52-Week RangeNear 52-week low
$164.92th %ile$235.8
Earnings & Analysts

ANALYST ESTIMATES

Consensus of 16 analysts
Analyst revisions:EPS↑ Revised UpRevenue↑ Revised Up

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2023
$22.7B
$22.0B$23.0B
$7.94
±3%
High7
FY2024
$24.4B
$24.0B$24.6B
+7.4%$8.69+9.5%
±2%
High14
FY2025
$26.9B
$26.7B$27.1B
+10.6%$9.60+10.5%
±1%
High16
Range confidence:Tight (high)ModerateWide (low)
🔥Beat 7 consecutive quarters
Earnings HistoryMRSH
Last 8Q
+3.1%avg beat
Beat 7 of 8 quarters Estimates rising
Q3'24
+1%
Q4'24
+6%
Q1'25
+1%
Q2'25
+2%
Q3'25
+4%
Q4'25
+8%
Q1'26
+2%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →
Neutral — mixed activity
90d10
Raymond JamesOutperform → Strong Buy
Feb 17
UPGRADE
BarclaysEqual-Weight → Overweight
Nov 20
UPGRADE
Bank of America Sec…Neutral → Underperform
Nov 3
DOWNGRADE
Goldman SachsSell → Neutral
Oct 20
UPGRADE
BMO CapitalOutperform
Jun 28
UPGRADE
Piper SandlerNeutral
Apr 17
DOWNGRADE
Bank of America Sec…Neutral
Jul 21
UPGRADE
Evercore ISIOutperform
Jun 8
UPGRADE
Atlantic EquitiesNeutral
Nov 8
DOWNGRADE
Zacks Investment Re…Sell
Apr 26
DOWNGRADE
Insider Activity
SEC Filings →
0 Buys/4 SellsNet Selling
Jones John JudeChief Marketin…
$410K
Mar 11
SELL
Doyle John QPresident and …
$3.1M
Mar 4
SELL
Studer Nicholas MarkPresident and …
$706K
Mar 3
SELL
Doyle John QPresident and …
$3.8M
Dec 1
SELL
Financials
Dividends2.17% yield
+5.8% avg annual growth
Annual Yield2.17%
Quarterly Div.$0.9000
Est. Annual / Share$3.60
FrequencyQuarterly
Q3'24
Q4'24
Q1'25
Q2'25
Q3'25
Q4'25
Q1'26
Q2'26

Dividend per payment — last 8 periods

News & Activity

MRSH News

20 articles · 4h ago

About

No company information available